Regeneron Pharmaceuticals
REGN
#285
Rank
HK$598.75 B
Marketcap
HK$5,649
Share price
4.86%
Change (1 day)
-6.26%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): HK$40.12 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are HK$14.24 Billion. In 2024 the company made an earning of HK$37.18 Billion, an increase over its 2023 earnings that were of HK$32.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$40.12 B7.9%
2024 HK$37.18 B13.83%
2023 HK$32.66 B-13.57%
2022 HK$37.79 B-47.9%
2021 HK$72.54 B144.75%
2020 HK$29.64 B56.86%
2019 HK$18.89 B-4.87%
2018 HK$19.86 B22.86%
2017 HK$16.16 B56.3%
2016 HK$10.34 B8.55%
2015 HK$9.53 B54.53%
2014 HK$6.16 B11.14%
2013 HK$5.54 B72.13%
2012 HK$3.22 B-285.93%
2011 -HK$1.74 Billion121.73%
2010 -HK$0.79 Billion37.18%
2009 -HK$0.58 Billion-14.6%
2008 -HK$0.67 Billion-25.02%
2007 -HK$0.9 Billion6.32%
2006 -HK$0.84 Billion-186.52%
2005 HK$0.96 B2103.7%
2004 HK$43.92 M-105.66%
2003 -HK$0.78 Billion-18.18%
2002 -HK$0.95 Billion42.33%
2001 -HK$0.67 Billion129.35%
2000 -HK$0.3 Billion51.87%
1999 -HK$0.2 Billion92.19%
1998 -HK$99.58 Million66.23%
1997 -HK$59.9 Million-55.49%
1996 -HK$0.14 Billion103.53%
1995 -HK$66.13 Million-70.89%
1994 -HK$0.23 Billion-26.08%
1993 -HK$0.31 Billion114.67%
1992 -HK$0.15 Billion196.77%
1991 -HK$48.24 Million87.88%
1990 -HK$25.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$64.13 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$1.01 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$14.81 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.01 B 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.72 B 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$70.79 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France